Re-evaluation of potential predictors of calretinin and mesothelin in a population-based cohort study using assays for the routine application in clinical medicine.
Swaantje CasjensGeorg JohnenIrina RaikoBeate PeschDirk TaegerCarmen TöpferSandra SchonefeldSusanne MoebusKarl-Heinz JöckelThomas BrüningDaniel WeberPublished in: BMJ open (2021)
The newly available assays of calretinin and mesothelin approved for clinical diagnostics showed high specificities in the population-based cohort of elderly men without a malignant disease. The current evaluation provides a basis to consider influencing factors in order to further improve the diagnostic procedure.